New emerging drug-resistant malaria

International Journal of General Medicine

Volumn 3, Issue , 2010, Pages 327-329

  Wiwanitkit, Viroj ^a  

^a WIWANITKIT HOUSE   (Thailand)

Author keywords

Drug resistance; Malaria

Indexed keywords

ARTEMISIN; ARTESUNATE;

ARTICLE; ECONOMIC ASPECT; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION RISK; LONG TERM CARE; MALARIA FALCIPARUM; OUTCOME ASSESSMENT; SOUTHEAST ASIA; TRAVEL;

EID: 79959242523     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, et al. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Trop Med Public Health. 2001;32:41-49.
2. Foster S, Phillips M. Economics and its contribution to the fight against malaria. Ann Trop Med Parasitol. 1998;92:391-398.
3. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L. Artemisinin resistance: current status and scenarios for containment Nature Rev Microbiol. 2010;8:272-280.
4. Babiker A, Garner P, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9-17.
5. Obonyo CO, Juma EA, Ogutu BR, et al. Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a metaanalysis. Trans R Soc Trop Med Hyg. 2007;101:117-126.
6. Bukirwa H, Critchley J. Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria. Cochrane Database Syst Rev. 2006;1:CD004966.
7. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455-467.